Sandoz Inc. and Pfizer Inc. are among 26 pharmaceutical companies that failed to convince a federal judge to end litigation ...

Eli Lilly’s ($LLY) Mounjaro and Pfizer’s ($PFE) cancer drugs were added to China’s state-run health insurance scheme, ...

Pfizer (PFE), and Johnson & Johnson (JNJ) secured spots on China's first innovative drug catalog for private insurance, ...

Pfizer has unveiled phase 3 results that could help the company’s hemophilia drug Hympavzi level the playing field in its ...

Pfizer will pay $94 million to resolve allegations that it used fraudulent patents to delay generic competition for its anti-inflammatory drug Celebrex. The lawsuit, brought by 32 direct purchasers of ...

The FDA is investigating a safety signal from Takeda’s rare disease med Adzynma. Otsuka won a first-in-class FDA approval to ...

More than a year after its promised deadline to investors, drugmaker puts alarming results in federal government's "virtual ...

Pfizer (NYSE: PFE) and Teva Pharmaceutical Industries (NYSE: TEVA) just reported third-quarter earnings that reveal two ...

(Reuters) - Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of ...

The generic version will be distributed to 95 low- and middle-income countries. The United Nations-backed Medicines Patent Pool announced Thursday it has signed an agreement with 35 companies around ...

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

As China's aging population increases demand for therapies treating everything from cancer and diabetes to dementia, the ...